Femoral and radial artery access continue to be the standard of care for percutaneous coronary interventions. Cardiac catheterization has progressed to encompass a wide range of diagnostic and interventional procedures including coronary, peripheral, endovascular, and structural heart disease interventions. Despite advanced technology to make these procedures safe, bleeding, and vascular complications continue to be a substantial source of morbidity, especially in patients undergoing large-bore access procedures. New variations of percutaneous devices have reduced complications associated with these procedures. However, safe vascular access with effective hemostasis requires special techniques which have not been well described in the literature. Large-bore femoral artery access is feasible, safe, and associated with low complication rates when a protocol is implemented. Wayne State University, Detroit Medical Center Heart Hospital is a tertiary care, high-volume center for endovascular, structural heart and complex high risk indicated procedures with more 150 procedures involving mechanical circulatory support (MCS) devices per year. In this manuscript, we describe our approach to femoral artery large-bore sheath insertion and management.
morbidity especially in patients undergoing large-bore access procedures. [4] [5] [6] Although femoral access is the most common approach in the United States, adoption of transradial access has been increasing. [7] [8] [9] Over the years, elderly patients with multiple comorbidities are increasingly referred for high risk structural and endovascular interventions that often require mechanical circulatory support (MCS). These new and advanced technologies require large-bore arterial accesses. 10, 11 This article will address large-bore sheath insertion, maintenance, and removal. Techniques for the maintenance of lower limb perfusion during large-bore sheath access and the management of vascular complications will also be discussed in detail.
| Impact of peripheral vascular disease on vascular access
The size of the iliac and common femoral arteries varies greatly, depending mainly on the patient body habitus and may be affected by the extent of atherosclerosis and tortuosity. 12, 13 Peripheral vascular disease (PVD) and coronary artery disease (CAD) have similar risk factors, and thus, it is common to encounter the challenge of treating structural or complex high-risk indicated patients (CHIP) with concomitant significant PVD. 14, 15 Small caliber common femoral and iliac arteries (less than 5.5 mm) with significant PVD increase the risk for vascular complications. The risk increases even more when larger bore sheaths are used. 6, [16] [17] [18] In some patients, femoral vascular access is prohibitive or carries extreme risk due to small caliber, complete occlusion, or severe calcification. This is often discovered at the time of procedure as patient presenting with acute coronary syndrome or cardiogenic shock that requires immediate attention and access for mechanical support. In these cases, alternative arterial access sites such as axillary artery, carotid artery, subclavian artery, transcaval, and direct transapical approaches. After the first arterial access is established, performing angiography of the iliac bifurcation with right and/or left iliac arteries to define the access site and vessels anatomy is recommended ( Figure 1 ). This approach is also used to define the anatomy of the contralateral vessel using 10 mL of contrast media injected from contralateral side using 5 wire, prior to placement of the large sheath.
| Maintaining lower extremity perfusion
After the large-bore sheath is positioned and secured, it is crucial to assess vessel patency and assure preserved distal perfusion into the extremity ( Figure 2 ). An aorto-iliac angiogram is performed by contrast injection through the large-bore sheath's side arm or by using selective catheter engagement into the ipsilateral iliac artery from an additional arterial access. The extremities are able to tolerate low perfusion state for short periods of time (less than 30 min). 32 However, when limb perfusion is compromised it may be necessary to establish flow distally by ex-vivo ipsilateral bypass using antegrade access technique.
For patients presented to the cath lab with cardiogenic shock or elective high-risk coronary intervention, Impella 2.5 or CP have been the device of choice in the US. Impella 2.5 and CP provide direct cardiac pressure and volume unloading of the left ventricle and antegrade flow in the thoracic aorta of up to 2.5 and 4.0 L/min, respectively. The catheter-based device is typically inserted through a peripheral access using a single arterial access of 13 Fr and 14 Fr, respectively. Impella has a specially designed two-step peel away sheath with a tapered shaft (14-French base to 9-French tip) that allows for adequate blood flow even in smaller caliber ilio-femoral arterial vessels. Once Impella device is positioned in place, the peel-away sheath then removed and repositioning sheath is advanced to the access site.
| Reperfusion techniques
PVD and CAD have similar risk factors, and thus, it is common to encounter the challenge of treating structural or complex coronary patients with significant concomitant PAD. 14, 15, 33 Small caliber common femoral and iliac arteries with severe PAD significantly increase the risk for vascular complications. That risk increases greatly as the larger bore sheaths are used.
6,16-18 Insertion of large bore sheath may result in complete vessel occlusion and acute limb ischemia that may threaten limb viability. It is therefore important to ensure adequate perfusion to the limb by careful assessment of the iliofemoral artery prior to insertion of large bore sheath. A challenging clinical scenario often encountered in practice is a patient who is hemodynamically dependent on a shortterm mechanical support device and whose large bore sheath is found to be occlusive. Several interventions can be performed in the setting of an occlusive sheath to restore perfusion to the distal lower extremity in such patients.
| Peel away sheath
The Impella mechanical support device comes with a specially 
| Sheath removal and hemostasis
Hemostasis after removal of small arterial sheaths is often achieved with manual compression, or with arterial closure devices that are readily available. Larger sheaths have been associated with worse outcome due to bleeding and vascular complications. 6 Removal of with lack of proficiency with the selected device. 37 Several new large caliber VCD are in development for structural heart interventions, and are undergoing clinical investigation. 38 For patients treated with Impella and require delayed hemostasis, the closure system needs to be sterilized, and secured especially if MCS is indicated for several days. Our practice is to sterilize the Perclose sutures, snare knot pusher, and suture trimmer with chlorhexidine gluconate (ChloraPrep®) and use Tegaderm to keep them separate and away from the access site. We then re-sterilize the site with ChloraPrep and wrap all Perclose parts with sterile towels. 39 We keep the Perclose sutures under the Tegaderm for 2-3 days on average. The duration depends on severity of current shock and time to recovery.
| Temporary endovascular balloon tamponade
The temporary endovascular balloon tamponade or "dry field closure may be sufficient to achieve hemostasis. Rarely, the arteriotomy site may continue to bleed after this intervention. In that case, a covered stent can be deployed at the arteriotomy site to achieve hemostasis. After sheath removal, it is recommended to perform complete angiography of the arteriotomy site and runoff to the tibio-peroneal trifurcation at the end of procedure to assure distal vessels patency.
| Vascular pseudoaneurysm
In a patient with a recent history of femoral artery puncture the presence of pain, swelling, and a palpable mass in the groin should prompt further investigation. The mass may be pulsatile with a thrill or bruit.
Complications can arise due to mass effect. Arteriotomy below the CFA bifurcation is associated with an increased risk of local hematoma and pseudoaneurysm formation owing to the lack of the posterior anchoring 
| Bleeding
The femoral artery is a large-caliber vessel with diameter ranging from 8 to 9 mm in normal adults which accommodate large sheaths. 6, 46 The femoral artery enters the retroperitoneal space before joining the iliac artery. If the arteriotomy site is too high, this may lead to a retroperitoneal hematoma. This is a rare complication of femoral artery access, but is associated with high mortality. 47 It is imperative to have high level of suspicion for these complications and develop a protocol for prompt identification and management. The first step is to prevent ongoing extravasation. This is achieved by inflating a balloon at low pressure to cover the site of perforation. While bleeding is controlled, a covered stent is rapidly deployed. Simultaneously, a vascular surgeon should be notified and made ready for possible emergent transfer of the patient for emergency surgery in the event percutaneous management of this complication fails.
| CONCLUSION
Arterial access and hemostasis are fundamental aspects of cardiac catheterization and intervention. In recent years, large-bore sheaths 
CLINICAL PERSPECTIVES
Despite the increasing use large-bore femoral accesses, there are no unified protocols to guide the large-bore femoral technique. This article provides strategies for placement, removal, and complication management to serve as a guide for interventional cardiologists who use large-bore femoral arterial access and includes several techniques that were developed over the last decade at our center with the experience of thousands of large-bore femoral arterial procedures.
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